33946588|t|Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.
33946588|a|Alzheimer's disease (AD) is caused by neurodegenerative, but also vascular and hemostatic changes in the brain. The oral thrombin inhibitor dabigatran, which has been used for over a decade in preventing thromboembolism and has a well-known pharmacokinetic, safety and antidote profile, can be an option to treat vascular dysfunction in early AD, a condition known as cerebral amyloid angiopathy (CAA). Recent results have revealed that amyloid-beta proteins (Abeta), thrombin and fibrin play a crucial role in triggering vascular and parenchymal brain abnormalities in CAA. Dabigatran blocks soluble thrombin, thrombin-mediated formation of fibrin and Abeta-containing fibrin clots. These clots are deposited in brain parenchyma and blood vessels in areas of CAA. Fibrin-Abeta deposition causes microvascular constriction, occlusion and hemorrhage, leading to vascular and blood-brain barrier dysfunction. As a result, blood flow, perfusion and oxygen and nutrient supply are chronically reduced, mainly in hippocampal and neocortical brain areas. Dabigatran has the potential to preserve perfusion and oxygen delivery to the brain, and to prevent parenchymal Abeta-, thrombin- and fibrin-triggered inflammatory and neurodegenerative processes, leading to synapse and neuron death, and cognitive decline. Beneficial effects of dabigatran on CAA and AD have recently been shown in preclinical studies and in retrospective observer studies on patients. Therefore, clinical studies are warranted, in order to possibly expand dabigatran approval for repositioning for AD treatment.
33946588	0	19	Alzheimer's Disease	Disease	MESH:D000544
33946588	64	72	Thrombin	Gene	2147
33946588	83	93	Dabigatran	Chemical	MESH:D000069604
33946588	95	114	Alzheimer's disease	Disease	MESH:D000544
33946588	116	118	AD	Disease	MESH:D000544
33946588	133	150	neurodegenerative	Disease	MESH:D019636
33946588	216	224	thrombin	Gene	2147
33946588	235	245	dabigatran	Chemical	MESH:D000069604
33946588	299	314	thromboembolism	Disease	MESH:D013923
33946588	408	428	vascular dysfunction	Disease	MESH:D002561
33946588	438	440	AD	Disease	MESH:D000544
33946588	463	490	cerebral amyloid angiopathy	Disease	MESH:D016657
33946588	492	495	CAA	Disease	MESH:D016657
33946588	555	560	Abeta	Gene	351
33946588	563	571	thrombin	Gene	2147
33946588	642	661	brain abnormalities	Disease	MESH:D001927
33946588	665	668	CAA	Disease	MESH:D016657
33946588	670	680	Dabigatran	Chemical	MESH:D000069604
33946588	696	704	thrombin	Gene	2147
33946588	706	714	thrombin	Gene	2147
33946588	748	753	Abeta	Gene	351
33946588	855	858	CAA	Disease	MESH:D016657
33946588	867	872	Abeta	Gene	351
33946588	933	943	hemorrhage	Disease	MESH:D006470
33946588	1041	1047	oxygen	Chemical	MESH:D010100
33946588	1144	1154	Dabigatran	Chemical	MESH:D000069604
33946588	1199	1205	oxygen	Chemical	MESH:D010100
33946588	1256	1261	Abeta	Gene	351
33946588	1264	1272	thrombin	Gene	2147
33946588	1295	1307	inflammatory	Disease	MESH:D007249
33946588	1312	1329	neurodegenerative	Disease	MESH:D019636
33946588	1360	1376	and neuron death	Disease	MESH:D009410
33946588	1382	1399	cognitive decline	Disease	MESH:D003072
33946588	1423	1433	dabigatran	Chemical	MESH:D000069604
33946588	1437	1440	CAA	Disease	MESH:D016657
33946588	1445	1447	AD	Disease	MESH:D000544
33946588	1537	1545	patients	Species	9606
33946588	1618	1628	dabigatran	Chemical	MESH:D000069604
33946588	1660	1662	AD	Disease	MESH:D000544
33946588	Positive_Correlation	MESH:D006470	351
33946588	Association	MESH:D001927	2147
33946588	Association	MESH:D019636	351
33946588	Positive_Correlation	MESH:D000069604	MESH:D009410
33946588	Negative_Correlation	MESH:D000069604	MESH:D002561
33946588	Association	MESH:D000069604	MESH:D010100
33946588	Negative_Correlation	MESH:D000069604	MESH:D003072
33946588	Positive_Correlation	MESH:D007249	2147
33946588	Negative_Correlation	MESH:D000069604	MESH:D007249
33946588	Negative_Correlation	MESH:D000069604	MESH:D016657
33946588	Negative_Correlation	MESH:D000069604	351
33946588	Negative_Correlation	MESH:D000069604	MESH:D000544
33946588	Negative_Correlation	MESH:D000069604	MESH:D013923
33946588	Negative_Correlation	MESH:D000069604	2147
33946588	Association	MESH:D016657	351
33946588	Association	MESH:D001927	351
33946588	Association	MESH:D016657	2147
33946588	Positive_Correlation	MESH:D007249	351
33946588	Negative_Correlation	MESH:D000069604	MESH:D019636

